Genesis Therapeutics · Series B
AI drug-discovery company building generative and predictive models to design small-molecule
Amount
$200M
Round
Series B
Valuation
—
Announced
—
Investors
Participating investors
Other Genesis Therapeutics rounds
| Date | Round | Amount | |
|---|---|---|---|
| May 2026 | Strategic Equity Investment | $40M | Details → |